Literature DB >> 28320728

Impact of Mutations at Arg220 and Thr237 in PER-2 β-Lactamase on Conformation, Activity, and Susceptibility to Inhibitors.

Melina Ruggiero1,2, Lucrecia Curto3,4, Florencia Brunetti1, Eric Sauvage5, Moreno Galleni5, Pablo Power6,2, Gabriel Gutkind6,2.   

Abstract

PER-2 accounts for up to 10% of oxyimino-cephalosporin resistance in Klebsiella pneumoniae and Escherichia coli in Argentina and hydrolyzes both cefotaxime and ceftazidime with high catalytic efficiencies (kcat/Km ). Through crystallographic analyses, we recently proposed the existence of a hydrogen bond network connecting Ser70-Gln69-oxyanion water-Thr237-Arg220 that might be important for the activity and inhibition of the enzyme. Mutations at Arg244 in most class A β-lactamases (such as TEM and SHV) reduce susceptibility to mechanism-based inactivators, and Arg220 in PER β-lactamases is equivalent to Arg244. Alterations in the hydrogen bond network of the active site in PER-2, through modifications in key residues such as Arg220 and (to a much lesser extent) Thr237, dramatically impact the overall susceptibility to inactivation, with up to ∼300- and 500-fold reductions in the rate constant of inactivation (kinact)/Ki values for clavulanic acid and tazobactam, respectively. Hydrolysis on cephalosporins and aztreonam was also affected, although to different extents compared to with wild-type PER-2; for cefepime, only an Arg220Gly mutation resulted in a strong reduction in the catalytic efficiency. Mutations at Arg220 entail modifications in the catalytic activity of PER-2 and probably local perturbations in the protein, but not global conformational changes. Therefore, the apparent structural stability of the mutants suggests that these enzymes could be possibly selected in vivo.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Arg220; ESBL; Thr237; cefotaximase; ceftazidimase; inhibitor resistant; mechanism-based inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28320728      PMCID: PMC5444140          DOI: 10.1128/AAC.02193-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Effects of serine-to-cysteine mutations on beta-lactamase folding.

Authors:  Javier Santos; Valeria A Risso; Mauricio P Sica; Mario R Ermácora
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

Review 3.  IRT and CMT beta-lactamases and inhibitor resistance.

Authors:  R Cantón; M I Morosini; O Martín; O Martín S de la Maza; E Gomez G de la Pedrosa
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

4.  Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.

Authors:  Jodi M Thomson; Anne M Distler; Fabio Prati; Robert A Bonomo
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

5.  Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Kerri M Smith; Yan Xu; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

6.  Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases.

Authors:  María Margarita Rodríguez; Pablo Power; Marcela Radice; Carlos Vay; Angela Famiglietti; Moreno Galleni; Juan A Ayala; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

8.  Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.

Authors:  Melina Ruggiero; Frédéric Kerff; Raphaël Herman; Frédéric Sapunaric; Moreno Galleni; Gabriel Gutkind; Paulette Charlier; Eric Sauvage; Pablo Power
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

Review 9.  The chemistry and structure-activity relationships of C3-quaternary ammonium cephem antibiotics.

Authors:  A Laws; M Page
Journal:  J Chemother       Date:  1996-02       Impact factor: 1.714

10.  Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  P Nordmann; E Ronco; T Naas; C Duport; Y Michel-Briand; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  3 in total

1.  Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Authors:  José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez
Journal:  Curr Microbiol       Date:  2019-02-19       Impact factor: 2.188

2.  Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans.

Authors:  Michiyoshi Nukaga; Michael J Yoon; Magdalena A Taracilia; Tyuji Hoshino; Scott A Becka; Elise T Zeiser; Joseph R Johnson; Krisztina M Papp-Wallace
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

3.  Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam.

Authors:  Sebastián Klinke; Pablo Power; Barbara Ghiglione; María Margarita Rodríguez; Florencia Brunetti; Krisztina M Papp-Wallace; Ayumi Yoshizumi; Yoshikazu Ishii; Robert A Bonomo; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.